20
Participants
Start Date
October 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Atorvastatin
Participants will be orally administering one tablet daily of 40 mg Atorvastatin for two weeks followed by two tablets daily for two weeks (totalling 80 mg daily).
Placebo
Placebo tablets are manufactored by the Central Pharmacy of the Capital Region of Denmark and are identical to the IMP except with the active ingredient (atorvastatin) omitted. Participants will be orally administering one tablet daily for two weeks followed by two tablets daily for two weeks.
RECRUITING
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup
Fonden til Lægevidenskabens Fremme
OTHER
Prosektor Axel Søeborg Ohlsens Mindelegat
OTHER
Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat
OTHER
Asger Lund, MD
OTHER